Researcher Explains Why Africa Accounts for 42% of $200 Billion Fake Drugs
Oluwole Ojewale, the Regional Organised Crime Observatory Coordinator – Central Africa, for Institute for Security Studies’ (ISS) ENACT, has advanced reasons why Africa is accounting for around 42% of this $200 billion global demand for counterfeit medicines.
Rabat Saléemmour Zaëmo Oluwole Ojewale Institute For Security Studie Consumer Affairs Directorate United Nations Office On Drugs Association Of Gabonese Pharmacist
Source: thenews-chronicle.com